Bruker (NASDAQ:BRKR – Get Free Report) posted its quarterly earnings data on Thursday. The medical research company reported $0.53 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.07, Briefing.com reports. Bruker had a return on equity of 29.94% and a net margin of 14.41%. The firm had revenue of $721.70 million for the quarter, compared to analysts’ expectations of $729.88 million. During the same period in the previous year, the firm earned $0.64 EPS. The business’s quarterly revenue was up 5.3% on a year-over-year basis. Bruker updated its FY24 guidance to $2.79-2.84 EPS.
Bruker Stock Down 0.1 %
BRKR stock traded down $0.05 during trading on Friday, hitting $70.05. 1,959,840 shares of the company’s stock traded hands, compared to its average volume of 860,901. The business has a fifty day simple moving average of $87.68 and a two-hundred day simple moving average of $75.00. The company has a quick ratio of 0.99, a current ratio of 1.80 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $10.18 billion, a P/E ratio of 23.99, a PEG ratio of 2.00 and a beta of 1.22. Bruker has a 1 year low of $53.79 and a 1 year high of $94.86.
Bruker Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Friday, March 1st were issued a $0.05 dividend. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $0.20 annualized dividend and a dividend yield of 0.29%. Bruker’s dividend payout ratio is currently 6.85%.
Wall Street Analyst Weigh In
Get Our Latest Research Report on Bruker
Insider Buying and Selling at Bruker
In other Bruker news, Director Hermann Fritz Requardt sold 15,000 shares of the company’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $90.06, for a total transaction of $1,350,900.00. Following the transaction, the director now owns 23,147 shares in the company, valued at approximately $2,084,618.82. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 28.30% of the company’s stock.
About Bruker
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
Recommended Stories
- Five stocks we like better than Bruker
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- How to invest in marijuana stocks in 7 steps
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- How to Buy Cheap Stocks Step by Step
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.